Vitamin D deficiency and vitamin D therapy in chronic hepatitis C

Annals of Hepatology

Volumn 12, Issue 2, 2013, Pages 199-204

  Ladero, José M ^a   Torrejón, María J ^b   Sánchez Pobre, Pilar ^b   Suárez, Avelina ^b   Cuenca, Francisca ^b   de la Orden, Virginia ^b   Devesa, María J ^b   Rodrigo, María ^b   Estrada, Vicente ^b   López Alonso, Gustavo ^b   Agúndez, José A ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Calcitriol; Fibrosis; Hepatitis C virus; IL28B

Indexed keywords

COLECALCIFEROL; INTERFERON; VITAMIN D; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; DRUG DERIVATIVE; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; VIRUS RNA; VITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG EFFICACY; DRUG RESPONSE; ETHNIC GROUP; FEMALE; GENE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IL28B GENE; INCIDENCE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SPANISH; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; AGED; BLOOD; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; ELASTOGRAPHY; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; LIVER CIRRHOSIS; MIDDLE AGED; PREDICTIVE VALUE; RISK; SPAIN; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; INTERLEUKINS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; SPAIN; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84875545576     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31357-2     Document Type: Article

References (23)

1. Gutierrez JA, Parikh N, Branch AD. Classical and emerging roles of vitamin D in hepatitis C virus infection. Sem Liver Dis 2011; 31: 387-98.
2. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8-F28.
3. Cohen ML, Duovdevani A, Chaimovitz C, Shany S. Regulation of THF-alpha by 1alpha, 25-dyhydroxyvitamin D3 in human macrophages from CAPD patients. Kidney Int 2001; 59: 69-75.
4. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signalling and activation of human T cells. Nat Immunol 2010; 11: 344-9.
5. Chesney RW. Vitamin D and the magic mountain: the anti-infectious role of the vitamin. J Pediatr 2010; 156: 698-703.
6. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Endocrinol Metab 2011; 96: 1911-30.
7. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010; 55: 513-20.
8. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic liver disease. Clin Gastroenterol Hepatol 2007; 5: 513-20.
9. Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, Esteghamati A, Abdollahi A, Mazloumi M. Disturbances of parathyroid hormona-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int 2010; 4: 634-40.
10. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrman E, et al. Vitamin D deficiency and CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferonalfa based therapy. J Hepatol 2011; 54: 887-93.
11. Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, Poynard T, et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011; 55: 756-61.
12. Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51: 1158-67.
13. Bitetto D, Fattovich G, Fabris C, Ceriani A, Falleti E, Fornasiere E, Pasino M, et al. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011; 53: 1118-26.
14. Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, Bignulin S, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011; 24: 43-50.
15. Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina A-R, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. World J Gastroenterol 2011; 17: 5184-90.
16. Yano M, Ikeda M, Abe K, Dansako H, Ohkoshi S, Aoyagi Y, Kato N. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture. Antimicrob Agents Chemother 2007; 51: 2016-27.
17. Yano M, Ikeda M, Abe K, Kawai Y, Kuroki M, Mori K, Dansako H, et al. Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase. Hepatology 2009; 50: 678-88.
18. Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011; 54: 1570-9.
19. Agúndez JA, García-Martín E, Maestro ML, Cuenca F, Martinez C, Ortega L, Carballo M, et al. Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease. Plos One 2012; 7: e37998.
20. Hochwald O, Harman-Boehm I, Castel H. Hipovitaminosis D among inpatients in a sunny country. Isr Med Assoc J 2004; 6: 82-7.
21. González-Molero I, Morcillo S, Valdés S, Pérez-Valero V, Botas P, Delgado E, Hernández D, et al. Vitamin D deficiency in Spain: a population-based cohort study. Eur J Clin Nutr 2011; 65: 321-8.
22. Mezquita-Raya P, Muñoz-Torres M, Luna Juan D, Luna V, López-Rodríguez F, Torres-Vela E, Escobar-Jiménez F. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Min Res 2001; 16: 1408-15.
23. Ladero JM, García-Martín E, Fernández C, Carballo M, Devesa MJ, Martinez C, Suárez A, et al. Predicting response to therapy in chronic hepatitis C: an approach combining IL28B polymorphisms and clinical data. J Gastroenterol Hepatol 2012; 27: 279-85.